Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues.
Böszörményi KP, Stammes MA, Fagrouch ZC, Kiemenyi-Kayere G, Niphuis H, Mortier D, van Driel N, Nieuwenhuis I, Vervenne RAW, Haaksma T, Ouwerling B, Adema D, Acar RF, Zuiderwijk-Sick E, Meijer L, Mooij P, Remarque EJ, Oostermeijer H, Koopman G, Hoste ACR, Sastre P, Haagmans BL, Bontrop RE, Langermans JAM, Bogers WM, Kondova I, Verschoor EJ, Verstrepen BE. Böszörményi KP, et al. Among authors: verschoor ej. Viruses. 2021 Aug 23;13(8):1673. doi: 10.3390/v13081673. Viruses. 2021. PMID: 34452537 Free PMC article.
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
Verschoor EJ, Mooij P, Oostermeijer H, van der Kolk M, ten Haaft P, Verstrepen B, Sun Y, Morein B, Akerblom L, Fuller DH, Barnett SW, Heeney JL. Verschoor EJ, et al. J Virol. 1999 Apr;73(4):3292-300. doi: 10.1128/JVI.73.4.3292-3300.1999. J Virol. 1999. PMID: 10074183 Free PMC article.
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.
Heeney J, Akerblom L, Barnett S, Bogers W, Davis D, Fuller D, Koopman G, Lehner T, Mooij P, Morein B, de Giuli Morghen C, Rosenwirth B, Verschoor E, Wagner R, Wolf H. Heeney J, et al. Immunol Lett. 1999 Mar;66(1-3):189-95. doi: 10.1016/s0165-2478(98)00157-6. Immunol Lett. 1999. PMID: 10203054
116 results